|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2002-7-18
|
|
pubmed:abstractText |
To determine, in stage IV non-small-cell lung cancer (NSCLC), if the combination of gemcitabine-a new active drug-with ifosfamide (IG) or with the cisplatin-carboplatin association (CCG) will improve survival (primary end point) in comparison with a first-generation regimen, cisplatin-carboplatin-ifosfamide (CCI).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
pubmed-author:AlexopoulosC GCG,
pubmed-author:BerghmansTT,
pubmed-author:EfremidisAA,
pubmed-author:European Lung Cancer Working Party,
pubmed-author:FlorinM CMC,
pubmed-author:KlasterskyJJ,
pubmed-author:LafitteJ JJJ,
pubmed-author:LecomteJJ,
pubmed-author:MommenPP,
pubmed-author:NinaneVV,
pubmed-author:PaesmansMM,
pubmed-author:ReclouxPP,
pubmed-author:SculierJ PJP,
pubmed-author:ThiriauxJJ
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
874-82
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12123332-Adult,
pubmed-meshheading:12123332-Aged,
pubmed-meshheading:12123332-Antineoplastic Agents, Alkylating,
pubmed-meshheading:12123332-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12123332-Belgium,
pubmed-meshheading:12123332-Biopsy, Needle,
pubmed-meshheading:12123332-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:12123332-Deoxycytidine,
pubmed-meshheading:12123332-Disease-Free Survival,
pubmed-meshheading:12123332-Dose-Response Relationship, Drug,
pubmed-meshheading:12123332-Drug Administration Schedule,
pubmed-meshheading:12123332-Female,
pubmed-meshheading:12123332-Follow-Up Studies,
pubmed-meshheading:12123332-Humans,
pubmed-meshheading:12123332-Ifosfamide,
pubmed-meshheading:12123332-Lung Neoplasms,
pubmed-meshheading:12123332-Male,
pubmed-meshheading:12123332-Middle Aged,
pubmed-meshheading:12123332-Neoplasm Staging,
pubmed-meshheading:12123332-Probability,
pubmed-meshheading:12123332-Reference Values,
pubmed-meshheading:12123332-Remission Induction,
pubmed-meshheading:12123332-Survival Analysis,
pubmed-meshheading:12123332-Treatment Outcome
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancer.
|
|
pubmed:affiliation |
Institut Jules Bordet, Bruxelles, Belgium. sculier@bordet.be
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
